1992
Frequency and prognostic significance of clonal T-cell receptor beta-gene rearrangements in the peripheral blood of patients with mycosis fungoides
Search citation statements
Paper Sections
Select...
16
4
2
0
Citation Types
0
14
1
1
Year Published
1993
2024
Publication Types
Select...
17
2
Relationship
0
19
Authors
Journals
Cited by 19 publications
(16 citation statements)
References 0 publications
0
14
1
1
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Accordingly, as for circulating CD30+ cells, the detection of a dominant T‐cell clone in peripheral blood is not clearly related to the extension of the cutaneous lesions. Overall, these results contrast with data obtained from MF when a circulating clone can be detected in more than half of the patients even in the early, plaque‐like stages of the disease 20–25 …”
Section: Discussion
contrasting
confidence: 94%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Accordingly, as for circulating CD30+ cells, the detection of a dominant T‐cell clone in peripheral blood is not clearly related to the extension of the cutaneous lesions. Overall, these results contrast with data obtained from MF when a circulating clone can be detected in more than half of the patients even in the early, plaque‐like stages of the disease 20–25 …”
Section: Discussion
contrasting
confidence: 94%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…A clonal gene rearrangement in the peripheral blood was detected in 1/23 patients (4%) with plaque stage MF, 2/19 patients (10%) with tumour stage MF and 2/4 patients (50%) with erythrodermic MF. These authors suggested that CTCL patients with peripheral blood involvement have a significantly shorter survival time than patients without peripheral blood involvement [4]. We can speculate that multiple cutaneous involvement of a cutaneous lymphoma with the same T-cell clone is only possible by haematogenous or lymphogenous spread.…”
Section: Discussion
mentioning
confidence: 76%
“…In contrast, in all eight patients with PSL and in the LP patient, no gene rearrangements of TcR β or IgH were detected. Bakels et al [4] found TcR β rearrangements in peripheral blood samples in 5/46 patients (11%) with MF. A clonal gene rearrangement in the peripheral blood was detected in 1/23 patients (4%) with plaque stage MF, 2/19 patients (10%) with tumour stage MF and 2/4 patients (50%) with erythrodermic MF.…”
Section: Discussion
mentioning
confidence: 99%
Smart CitationsHow this paper cites the one you are viewing
“…A few papers dealing with extracutaneous involvement in MF confirm their findings by autopsies 10,13,[45][46][47][48][49][50][51][52][53] .…”
Section: Extracutaneous Involvement In Mf (Mf)
mentioning
confidence: 70%
“…From thisstudy it was concluded, that clonal TCR beta-generearrangements, as detected by Southem blot analysis, are uncommon in the peripheral blood of patients with MF, in particular in patients without histologically documented lymph node involvement 45 . Atypical lymphoma cells in the peripheral blood smear were detected in 22 of 115 (19%) patients, only 12 of which (10%) had 5% or more atypical lymphoma (or Sézary) cells [81].…”
Section: Peripheral Blood
mentioning
confidence: 80%
